Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday morning. Amgen Inc. (NASDAQ: AMGN) raised to Buy at Lazard. American Tower…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Thursday morning. Abercrombie & Fitch Co. (NYSE: ANF) cut to Neutral at Baird…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall St.research calls this Friday morning. Amgen Inc. (NASDAQ: AMGN) raised to Overweight at Piper Jaffray. Caterpillar Inc.…
We have many stocks on the move in the after-hours session. Today was the largest day for S&P earnings this earnings season. Some of these volume spikes are massive. Acme Packet, Inc.…
Amgen Inc. (NASDAQ: AMGN) today announced financial results for the second quarter of 2012. The biotech giant’s results showed a 13% revenue gain to $4.5 billion and adjusted earnings rose 34% to…
Jon C. Ogg Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall St. research calls this Wednesday morning. Amgen Corp. (NASDAQ: AMGN) raised to Outperform at Credit Suisse. Apple…
Thursday was D-Day for the Supreme Court decision on the Obama healthcare mandate as to its constitutionality. The long and short of it is that the mandate is constitutional as a tax…
24/7 Wall St. loves companies which send capital back to shareholders via dividends. With all of the uncertainty in today’s markets and in the fluctuating economy, having a solid dividend policy may…
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set…
When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance of really setting the trend for the entire biotech sector this…
Earnings season is in full swing and we have many key reports due in the coming week. 24/7 Wall St. has provided some detailed previews for the key earnings reports we expect…
AuthorDendreon Corp. (NASDAQ: DNDN), maker of prostate cancer drug Provenge, is once again rumored to be a takeover target. As Streetinsider.com points out, the company’s new chairman presided over the Eli Lilly…
You might have already heard the reports that Apple is sitting on a lot of cash, around the $100 billion mark. You might have even read the scores of recommendations about what…
The three major US equities indexes opened sharply lower this morning and the slide continued pretty much without interruption all day. About half an hour before closing, all three indexes are down…
Jon OggThese are some of this Tuesday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Cut to Market Perform at Bernstein. Annaly Capital Management, Inc. (NYSE:…
